Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Adducts and tamoxifen

H Busch1

  • 1Department of Pharmacology, Baylor College of Medicine, Houston, TX 77030, USA.

Seminars in Oncology
|February 1, 1997
PubMed
Summary
This summary is machine-generated.

Tamoxifen causes DNA damage in rat livers, but not in human tissues. This suggests different cancer mechanisms between rats and humans, impacting tamoxifen

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A region of antisense RNA from human p120 cDNA with high homology to mouse p120 cDNA inhibits NIH 3T3 proliferation.

Cancer research·1992
Same author

Increased growth of NIH/3T3 cells by transfection with human p120 complementary DNA and inhibition by a p120 antisense construct.

Cancer research·1992
Same author

Sp1 is essential and its position is important for p120 gene transcription: a 35 bp juxtaposed positive regulatory element enhances transcription 2.5 fold.

Nucleic acids research·1991
Same author

DNA footprint enhancement using tandem binding sites.

BioTechniques·1991
Same author

["I don't see medical reasons for a change". Dr. H. Busch, Münster, takes a position on prevention of pneumocystis carinii pneumonia with pentamidine aerosol. Interview by Wilma Mahler].

Fortschritte der Medizin·1991
Same author

Purification of a group of HeLa nuclear proteins that bind to a regulatory element (-1430/-1327) of the human proliferating cell nucleolar protein P120 gene.

Biochemical and biophysical research communications·1991

Area of Science:

  • Toxicology
  • Carcinogenesis
  • Molecular Biology

Background:

  • DNA-adducts are biomarkers of carcinogen exposure and can be found in various organs.
  • Tamoxifen's carcinogenicity in rat liver is linked to the formation of tamoxifen DNA-adducts.
  • Specific tamoxifen metabolites, like alpha-hydroxy tamoxifen, are suspected proximal carcinogens in rats.

Purpose of the Study:

  • To investigate the presence of tamoxifen-related DNA-adducts in human liver and endometrial tissues.
  • To compare the mechanism of tamoxifen carcinogenicity in rats versus humans.

Main Methods:

  • Analysis of DNA-adducts in human liver and endometrial samples from tamoxifen-treated patients.
  • Comparison of findings with existing data on tamoxifen DNA-adducts in rat liver cells.

Related Experiment Videos

Main Results:

  • No evidence of tamoxifen-related DNA-adducts was found in human liver or endometrial tissues.
  • Preliminary data suggest tamoxifen might reduce background DNA-adducts in some human tissues.
  • Lack of adducts in human samples contrasts with readily demonstrated DNA-adduct formation in rat liver.

Conclusions:

  • Tamoxifen's carcinogenic mechanism in humans, if any, differs from that observed in rat liver.
  • The absence of tamoxifen adducts in human tissues explains the lack of consistent clinical evidence for tamoxifen-induced liver cancer.
  • Further research is needed to elucidate the mechanism of tamoxifen's potential carcinogenicity in the human endometrium.